Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dopaminergic Mechanism of Working Memory in PD
NCT04968613Phase 4Unknown
- Sponsor
- Peking University Third Hospital
- Start
- Jan 2018
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of levodopa, benserazide, pramipexole, selegiline in Parkinson's disease (PD), sponsored by Peking University Third Hospital. Status: unknown.
02
Drugs
levodopabenserazidepramipexoleselegiline
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT04968613.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04968613.